Data / Research funding / Neonatal Respiratory Distress
Neonatal Respiratory Distress: 277 NIH awards ($351.3M) to 101 organizations
277 NIH awards ($351.3M) in the NIH spending category Neonatal Respiratory Distress, to 101 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
277 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Neonatal Research Network Data Coordinating Center (DCC) 2023-2028 | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $29,678,342 | September 1, 2025 | March 31, 2026 | DAS, ABHIK | reporter.nih.gov |
| Data Coordinating Center (DCC) for the Neonatal Opioid Withdrawal Syndrome Pharmacological Treatments Comparative Effectiveness Trial (NOWS PhaCET) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $25,628,714 | September 20, 2021 | August 31, 2027 | DAS, ABHIK | reporter.nih.gov |
| Safety of Sildenafil in Premature Infants with Severe Bronchopulmonary Dysplasia | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $6,819,944 | September 15, 2019 | August 31, 2025 | HORNIK, CHRISTOPH | reporter.nih.gov |
| The Darbepoetin Kindergarten Development Study | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $6,538,886 | September 1, 2023 | August 31, 2028 | BANN, CARLA M | reporter.nih.gov |
| Post-Vent, the Sequelae: Personalized Prognostic Modeling for Consequences of Neonatal Intermittent Hypoxemia in Preterm Infants at Pre-School Age | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $6,079,745 | December 15, 2021 | November 30, 2026 | WEESE-MAYER, DEBRA ELLYN | reporter.nih.gov |
| BioRepository for INvestigation of Diseases of the Lung (BRINDL) - Phase III | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $5,051,640 | August 23, 2019 | August 31, 2029 | PRYHUBER, GLORIA S | reporter.nih.gov |
| Aerosolized Vitamin A: Developing a Prevention for Hyperoxic Lung Injury and Bronchopulmonary Dysplasia, with Focus on Neonatal Lung Maturation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,252,869 | July 1, 2018 | February 28, 2027 | GELFAND, CRAIG | reporter.nih.gov |
| MSC Exosome Treatment for BPD: Impact on Immunity and Lung Development | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,182,213 | March 1, 2019 | February 28, 2027 | KOUREMBANAS, STELLA | reporter.nih.gov |
| Long-term Endotypes of Prematurity Associated Respiratory Disease (LEOPARD) | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $3,976,850 | August 15, 2024 | July 31, 2028 | HAMVAS, AARON | reporter.nih.gov |
| Mechanisms of newborn pulmonary hypertension caused by chronic intrauterine hypoxia | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,098,160 | January 1, 2022 | November 30, 2026 | BLOOD, ARLIN B | reporter.nih.gov |
| A Safer Glucocorticoid to Treat Neonatal Lung Injury with Limited Adverse Neurologic Effects | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $2,931,469 | September 1, 2021 | June 30, 2027 | DEFRANCO, DONALD B | reporter.nih.gov |
| 2/2 Neonatal Platelet Transfusion Threshold Trial (NeoPlaTT) | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $2,922,467 | May 15, 2024 | April 30, 2031 | DAS, ABHIK | reporter.nih.gov |
| Development of a systems pharmacology agent for treatment of bronchopulmonary dysplasia | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,920,336 | June 15, 2023 | May 31, 2026 | NAYLOR, STEPHEN | reporter.nih.gov |
| Research Center for Spatiotemporal Lung Imaging and Omics | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,809,161 | September 1, 2019 | July 31, 2025 | ADKINS, JOSHUA N. | reporter.nih.gov |
| Prdm3/16 Regulate Chromatin Accessibility to Determine Alveolar Maturation | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,805,992 | July 1, 2022 | June 30, 2027 | WHITSETT, JEFFREY A | reporter.nih.gov |
| Transfusion of Prematurity Early School Age Follow-up (TOP 5) DCC | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,727,857 | September 20, 2018 | August 31, 2025 | DAS, ABHIK | reporter.nih.gov |
| Decoding the Cellular Niches Critical for Lung Maturation and Pathogenesis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,704,970 | August 19, 2019 | June 30, 2025 | SUN, XIN | reporter.nih.gov |
| Consortium Of MRI Biomarkers In Neonatal Encephalopathy (COMBINE) | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2024 | $2,676,551 | May 1, 2022 | April 30, 2025 | GRANT, PATRICIA ELLEN | reporter.nih.gov |
| Maternal oxygen supplementation for Intrauterine Resuscitation: a Multicenter Randomized Trial | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,637,370 | September 16, 2022 | August 31, 2027 | RAGHURAMAN, NANDINI | reporter.nih.gov |
| Pericytes and postnatal alveolarization: Role of hypoxia inducible factors | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,591,893 | May 1, 2022 | April 30, 2026 | CORNFIELD, DAVID N. | reporter.nih.gov |
| Integrins in the Developing Lung | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,560,286 | August 1, 2022 | April 30, 2027 | PLOSA, ERIN J | reporter.nih.gov |
| Renal Anhydramnios Fetal Therapy (RAFT) Trial | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $2,540,189 | April 1, 2020 | February 28, 2026 | ATKINSON, MEREDITH ANN | reporter.nih.gov |
| Cellular Senescence in Neonatal Airways | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,503,972 | July 1, 2022 | June 30, 2027 | PRAKASH, Y. S. | reporter.nih.gov |
| Noninvasive Neonatal Blood Gas Monitoring | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $2,453,962 | August 7, 2025 | July 31, 2029 | EVANS, CONOR LEE | reporter.nih.gov |
| Multidimensional phenotype classification in grade 3 BPD | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,435,958 | June 1, 2023 | May 31, 2028 | LINGAPPAN, KRITHIKA | reporter.nih.gov |
| Cardiac Growth and Function Trajectories after Preterm Birth | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,418,062 | May 1, 2023 | April 30, 2028 | GOSS, KARA N | reporter.nih.gov |
| 2/2 Milrinone for Prevention of Post-Patent Ductus Arteriosus Closure Syndrome in Extremely Preterm Infants (MIDAS Trial) - DCC Resubmission | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $2,393,677 | July 1, 2024 | June 30, 2029 | DAS, ABHIK | reporter.nih.gov |
| Optimal Oxygenation in Neonatal Lung Injury | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $2,377,306 | August 1, 2023 | April 30, 2028 | LAKSHMINRUSIMHA, SATYANARAYANA | reporter.nih.gov |
| Trajectories of Regional Cardiopulmonary Structure and Function in A Longitudinal Cohort of Extremely Preterm Infants | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,365,315 | May 2, 2023 | February 29, 2028 | HYSINGER, ERIK BRADFORD | reporter.nih.gov |
| 1/2 The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,347,034 | September 17, 2021 | November 30, 2026 | FOGLIA, ELIZABETH | reporter.nih.gov |
| Developmental Origins of COPD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,338,162 | April 5, 2021 | March 31, 2025 | BENJAMIN, JOHN | reporter.nih.gov |
| Etiology and pathogenesis of lethal lung developmental disorders in neonates | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,325,410 | August 15, 2023 | May 31, 2027 | STANKIEWICZ, PAWEL | reporter.nih.gov |
| MRI Phenotyping of Severe BPD and Prediction of Outcomes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,292,490 | September 1, 2019 | June 30, 2029 | WOODS, JASON C | reporter.nih.gov |
| Gestational Hypoxia and Programming of Maternal, Fetal and Newborn Vascular Function | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,289,567 | July 1, 2020 | June 30, 2025 | ZHANG, LUBO | reporter.nih.gov |
| Role of neonatal lung macrophages in mediating resilience to hyperoxia induced lung injury via TREM2 signaling | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,257,286 | June 1, 2023 | February 29, 2028 | SAJTI, ENIKO | reporter.nih.gov |
| Developmental Heterogeneity of Pulmonary Endothelial Phenotype at Single Cell Resolution | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,206,652 | September 15, 2021 | December 1, 2024 | ALVIRA, CRISTINA MARIA | reporter.nih.gov |
| Transfusion of Prematurity Early School Age Follow-up (TOP 5) CCC | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,185,689 | September 20, 2018 | August 31, 2025 | CONRAD, AMY LYNN | reporter.nih.gov |
| Indoor Air Quality and Respiratory Morbidity in School-Aged Children with Bronchopulmonary Dysplasia | NIH | National Institute of Environmental Health Sciences | 2021 to 2023 | $2,182,320 | January 15, 2019 | June 30, 2025 | GAFFIN, JONATHAN MARK | reporter.nih.gov |
| Non-clinical Development of a Synthetic Lung Surfactant for Treatment of NRDS | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,169,278 | August 1, 2021 | May 31, 2023 | FUJII, GARY | reporter.nih.gov |
| Cardiovascular potassium channels: From molecular basis to disease therapeutics | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $2,160,901 | January 1, 2024 | December 31, 2030 | NICHOLS, COLIN G | reporter.nih.gov |
| Interplay between mechanical forces and retinoic acid in lung development | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,150,300 | January 1, 2022 | November 30, 2026 | NELSON, CELESTE M | reporter.nih.gov |
| Integrated Molecular and Cellular Drivers of Alveologenesis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,080,651 | May 20, 2023 | April 30, 2028 | SUCRE, JENNIFER MALCOLMSRYGLEY | reporter.nih.gov |
| PRISM | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $2,075,228 | September 15, 2023 | June 30, 2028 | LANG, JASON E. | reporter.nih.gov |
| Balancing Airway Progenitor versus Progeny: a Pathway from Mitochondria | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,054,106 | August 20, 2021 | June 30, 2026 | SUN, XIN | reporter.nih.gov |
| Optimization of Saturation Targets And Resuscitation Trial (OptiSTART) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,049,989 | July 21, 2022 | June 30, 2027 | KAPADIA, VISHAL S | reporter.nih.gov |
| The TELENEO Trial: A Multicenter Trial of Telemedicine for Advanced Neonatal Resuscitations in Community Hospitals | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $2,048,834 | September 1, 2023 | August 31, 2028 | FANG, JENNIFER L | reporter.nih.gov |
| A novel approach for prevention of Bronchopulmonary dysplasia in at-risk pre-term infants | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2023 | $2,015,197 | June 1, 2023 | April 30, 2024 | ACHARYA, SUCHISMITA | reporter.nih.gov |
| Preclinical Development of a ME-1001, a Synthetic Lung Surfactant | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,999,637 | May 15, 2024 | October 31, 2026 | FUJII, GARY | reporter.nih.gov |
| Phthalate Exposure and Mechanisms of Action in the Neonatal Intensive Care Unit | NIH | National Institute of Environmental Health Sciences | 2023 | $1,999,075 | September 1, 2023 | August 31, 2026 | STROUSTRUP, ANNEMARIE | reporter.nih.gov |
| Extending CPAP Therapy in Stable Preterm Infants to Increase Lung Growth and Function: A Randomized Controlled Trial | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,990,197 | September 28, 2020 | August 31, 2025 | MCEVOY, CYNTHIA T | reporter.nih.gov |
| Transcriptional Regulation of Endothelial Cells after Neonatal Lung Injury | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,984,340 | April 1, 2018 | June 30, 2027 | KALINICHENKO, VLADIMIR | reporter.nih.gov |
| Machine Learning and Multiomics for Predictive Models and Biomarker Discovery in Preterm Infants. | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $1,951,076 | September 1, 2023 | August 31, 2028 | PAMMI, MOHAN | reporter.nih.gov |
| Tissue niches for ILC3 development in newborn's lung | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,949,066 | January 1, 2021 | March 14, 2025 | DESHMUKH, HITESH | reporter.nih.gov |
| Exosomal Gasdermin D Mediated Lung to Brain Crosstalk in Preterm Brain Injury | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,938,967 | August 5, 2020 | June 30, 2025 | WU, SHU | reporter.nih.gov |
| Clinical Center for NICHD/Neonatal Research Network | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $1,907,014 | April 1, 2011 | March 31, 2030 | DEMAURO, SARA BONAMO | reporter.nih.gov |
| FGF18 regulation of postnatal lung development | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,875,324 | July 15, 2020 | June 30, 2025 | ORNITZ, DAVID M | reporter.nih.gov |
| Regulation of neonatal inflammation by myeloid-derived suppressor cells | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,864,330 | April 15, 2020 | December 31, 2025 | NEFEDOVA, YULIA | reporter.nih.gov |
| Unraveling the molecular origins of chronic parenchymal lung diseases | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,861,890 | September 1, 2024 | August 31, 2029 | KROPSKI, JONATHAN ANDREW | reporter.nih.gov |
| NICHD Neonatal Research Network -- Cincinnati Clinical Center | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $1,847,173 | April 1, 1991 | March 31, 2030 | MERHAR, STEPHANIE L | reporter.nih.gov |
| Regulation of mesenchymal cells by epithelial Wnt ligands | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,824,465 | March 1, 2016 | December 31, 2023 | CHEN, JICHAO | reporter.nih.gov |
| Pulmonary Complications in a Birth Cohort after a Randomized Trial of Antenatal Corticosteroids: the ALPS Follow-Up Study - Data Coordinating Center (ALPS FS - DCC) | NIH | National Heart, Lung, and Blood Institute | 2021 | $1,795,125 | August 5, 2010 | July 31, 2024 | CLIFTON, REBECCA GERSNOVIEZ | reporter.nih.gov |
| Hydrogen Sulfide in Neonatal Airway Disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,792,104 | January 1, 2023 | November 30, 2026 | PABELICK, CHRISTINA MARIA | reporter.nih.gov |
| Development of novel therapeutic approaches for treatment of Alveolar Capillary Dysplasia | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,783,643 | May 1, 2021 | May 31, 2029 | KALINICHENKO, VLADIMIR | reporter.nih.gov |
| 2/2 The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $1,782,742 | September 3, 2021 | November 30, 2026 | RATCLIFFE, SARAH J | reporter.nih.gov |
| Pulmonary implications of perinatal acetaminophen exposure | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $1,749,101 | April 1, 2022 | March 31, 2027 | WRIGHT, CLYDE JASON | reporter.nih.gov |
| Photochemical Generation of Gas Phase Nitric Oxide from Immobilized S-Nitrosothiols for Biomedical Applications | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $1,730,175 | September 1, 2019 | July 31, 2025 | WOLF, ALEXANDER KEITH | reporter.nih.gov |
| DLL4 in the Developing Lung and Bronchopulmonary Dysplasia (BPD) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,720,230 | February 1, 2023 | January 31, 2027 | SAMPATH, VENKATESH | reporter.nih.gov |
| Imaging biomarkers of severe respiratory infections in premature infants Phase II | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,678,216 | May 1, 2018 | July 31, 2025 | LINGURARU, MARIUS GEORGE | reporter.nih.gov |
| NICHD COPPERATIVE MULTICENTER NEONATAL RESEARCH NETWORK | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $1,662,403 | May 1, 2001 | March 31, 2030 | WYCKOFF, MYRA HELEN | reporter.nih.gov |
| NICHD Neonatal Research Network Clinical Center - Case Western Reserve University | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $1,661,242 | April 1, 1986 | March 31, 2030 | HIBBS, ANNA MARIA | reporter.nih.gov |
| Let-7b in BPD | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,652,040 | April 14, 2023 | March 31, 2027 | AMBALAVANAN, NAMASIVAYAM | reporter.nih.gov |
| North Carolina Clinical Center | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $1,626,461 | May 1, 2001 | March 31, 2030 | COTTEN, CHARLES MICHAEL | reporter.nih.gov |
| Integrative metabolomics of bronchopulmonary dysplasia in extremely low gestational age infants | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,615,000 | May 1, 2021 | February 28, 2026 | BALLARD, PHILIP L. | reporter.nih.gov |
| Phase 1 Safety, Pharmacokinetic study followed by Phase 2a Proof-of-Concept study of AVR-48, a small molecule macrophage modulator to prevent bronchopulmonary dysplasia in neonates | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $1,607,846 | April 12, 2024 | March 31, 2027 | ACHARYA, SUCHISMITA | reporter.nih.gov |
| Mechanisms of sex differences in neonatal pulmonary oxygen toxicity | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,602,313 | July 1, 2019 | June 30, 2026 | LINGAPPAN, KRITHIKA | reporter.nih.gov |
| Multi-organ protection from hyperoxia of the severely premature infant | NIH | National Eye Institute | 2021 to 2025 | $1,597,925 | August 1, 2015 | May 31, 2029 | SEARS, JONATHAN E | reporter.nih.gov |
| NICHD Cooperative Multicenter Neonatal Research Network - Utah Center | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $1,591,998 | April 1, 2016 | March 31, 2030 | OHLS, ROBIN K | reporter.nih.gov |
| Calculating the Components of Work of Breathing in Neonates with Bronchopulmonary Dysplasia | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,571,546 | August 15, 2024 | June 30, 2029 | BATES, ALISTER | reporter.nih.gov |
| NICHD Cooperative Multicenter Neonatal Research Network | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $1,540,928 | April 5, 2006 | March 31, 2030 | COLAIZY, TARAH TRINITY | reporter.nih.gov |
| NICHD Neonatal Research Network - Stanford University | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $1,539,549 | April 1, 1991 | March 31, 2030 | CHOCK, VALERIE | reporter.nih.gov |
| NICHD Neonatal Research Network Clinical Center UAB | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $1,535,314 | May 6, 1996 | March 31, 2030 | CARLO FONT, WALDEMAR A. | reporter.nih.gov |
| Eunice Kennedy Shriver NICHD Cooperative Multicenter Neonatal ResearchNetwork | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $1,530,482 | April 1, 2006 | March 31, 2030 | FULLER, JANELL | reporter.nih.gov |
| Optimizing Chest Compressions for Bradycardia during Neonatal Resuscitation | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $1,530,317 | May 1, 2021 | April 30, 2027 | CHANDRASEKHARAN, PRAVEEN | reporter.nih.gov |
| Fetal alcohol exposure: effects on immunity of the premature newborn | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2023 | $1,512,894 | August 20, 2019 | July 31, 2025 | GAUTHIER, THERESA WANZOR | reporter.nih.gov |
| Physiological Phenotyping of Respiratory Outcomes in Infants Born Premature | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,511,666 | March 1, 2019 | March 1, 2025 | TEPPER, ROBERT S. | reporter.nih.gov |
| NICHD Neonatal Research Network | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $1,499,248 | April 1, 1991 | March 31, 2030 | PATEL, RAVI MANGAL | reporter.nih.gov |
| Functional Validation of Novel Variants Associated with Congenital Diaphragmatic Hernia | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $1,493,151 | September 7, 2024 | July 31, 2029 | MURRAY, STEPHEN A | reporter.nih.gov |
| Defining how neonatal hyperoxia causes pulmonary hypertension in adults | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,389,146 | December 1, 2023 | November 30, 2027 | O'REILLY, MICHAEL A | reporter.nih.gov |
| Salivary Diagnostics for Sepsis Screening in the Neonate | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2023 | $1,365,552 | August 9, 2019 | April 30, 2025 | MARON, JILL LAMANNA | reporter.nih.gov |
| Real-time EIT pulmonary imaging for infants requiring ventilatory therapy | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $1,321,203 | July 1, 2024 | April 30, 2028 | MUELLER, JENNIFER LYNN | reporter.nih.gov |
| Elucidating the FOXF1 gene regulatory network in human alveologenesis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $1,307,495 | February 15, 2023 | January 31, 2028 | GU, MINGXIA | reporter.nih.gov |
| Role of Liver Kinase B1 in the decreased angiogenesis in bronchopulmonary dysplasia | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,290,900 | July 15, 2024 | June 30, 2028 | KONDURI, GIRIJA G. | reporter.nih.gov |
| Targeted metabolic profiling to predict major morbidity in very preterm newborns | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $1,258,832 | August 1, 2020 | September 1, 2022 | RYCKMAN, KELLI K. | reporter.nih.gov |
| Mechanisms in the Regulation of SP-A Gene Expression - Renewal - 1 - Resubmission | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,209,810 | April 1, 1993 | March 31, 2024 | MAHENDROO, MALA S. | reporter.nih.gov |
| Regulation of Neonatal Lung Inflammation by Novel Innate Immune Mechanisms | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,209,322 | August 1, 2024 | July 31, 2028 | POPOVA, ANTONIA PETROVA | reporter.nih.gov |
| S-Nitrosoglutathione therapy for oxidant disease of the neonatal airways and lung | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,184,606 | April 15, 2024 | January 31, 2028 | RAFFAY, THOMAS MICHAEL | reporter.nih.gov |
| HEAL initiative: Neonatal Opioid Withdrawal Syndrome Pharmacological Treatments Comparative Effectiveness Trial: Cincinnati site | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $1,166,467 | September 17, 2021 | August 31, 2026 | MERHAR, STEPHANIE L | reporter.nih.gov |
| Lung developmental defects caused by type I collagen mutations in mouse models of osteogenesis imperfecta | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,155,526 | September 1, 2023 | July 31, 2027 | MORELLO, ROY | reporter.nih.gov |
| Mechanical Control of Cell Proliferation and Branching Morphogenesis in the Embryonic Lung | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,142,223 | January 15, 2019 | December 31, 2025 | VARNER, VICTOR D. | reporter.nih.gov |
| MYRF as an Entry Point to Study Mesothelium Function in Lung Development and Injury Repair | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,141,652 | February 1, 2024 | December 31, 2027 | SUN, XIN | reporter.nih.gov |
| Targeted metabolic profiling to predict major morbidity in very preterm newborns | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2024 | $1,126,036 | August 1, 2020 | April 30, 2026 | RYCKMAN, KELLI K. | reporter.nih.gov |
| Incorporating nonpharmacologic approaches into a comparative effectiveness pharmacologic trial for neonates with neonatal opioid withdrawal syndrome (NOWS) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $1,123,480 | September 17, 2021 | August 31, 2026 | SOKOL, GREGORY M. | reporter.nih.gov |
| Metabolic mechanisms underlying bronchopulmonary dysplasia-associated pulmonary hypertension | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,117,040 | July 1, 2023 | April 30, 2027 | YAO, HONGWEI | reporter.nih.gov |
| UAB Clinical Site HEAL Neonatal Opioid Withdrawal Pharmacological Treatments | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $1,107,270 | September 17, 2021 | August 31, 2026 | AMBALAVANAN, NAMASIVAYAM | reporter.nih.gov |
| T Cells and IL-9 Signaling at the Maternal-Fetal Interface in Preterm Labor and Birth | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,096,566 | August 17, 2024 | June 30, 2029 | GOMEZ-LOPEZ, NARDHY | reporter.nih.gov |
| Development of novel therapeutic approaches for treatment of Alveolar Capillary Dysplasia | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,086,794 | May 1, 2021 | March 3, 2023 | KALINICHENKO, VLADIMIR | reporter.nih.gov |
| Modeling fetal lung development in congenital diaphragmatic hernia | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,057,973 | August 15, 2024 | May 31, 2028 | KUNISAKI, SHAUN MICHAEL | reporter.nih.gov |
| WNT5a Regulates Lung Maturation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,044,242 | March 6, 2019 | February 29, 2024 | LI, CHANGGONG | reporter.nih.gov |
| Effects of Platelet Transfusions on Neonatal Chronic Lung Disease and Sepsis-Induced Mortality | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $1,042,475 | May 15, 2021 | April 30, 2026 | DAVENPORT, PATRICIA ELLEN | reporter.nih.gov |
| MTDNA HAPLOGROUPS IN BPD | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,036,046 | June 1, 2024 | March 31, 2029 | KANDASAMY, JEGEN | reporter.nih.gov |
| NICHD Neonatal Research Network (NRN): Clinical Centers (UG1 Clinical Trial Optional | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $1,029,567 | April 1, 2023 | March 31, 2030 | RYSAVY, MATTHEW ALBERT | reporter.nih.gov |
| Sharp Neonatal Research Institute Clinical Center (Sharp NRI-CC) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $1,018,380 | April 1, 2023 | March 31, 2030 | KATHERIA, ANUP C | reporter.nih.gov |
| Regulation of PDE3 in the Pathobiology of Pulmonary Hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,012,887 | March 1, 2018 | December 31, 2024 | CHEN, BERNADETTE | reporter.nih.gov |
| Neonatal Research Network: the Lurie Children's - Northwestern University Study Center | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $990,437 | April 1, 2023 | March 31, 2030 | HAMVAS, AARON | reporter.nih.gov |
| 2/2 Hydrocortisone for BPD Respiratory and Developmental Outcomes Study (HYBRiD Outcomes Study): Data Coordinating Center | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $974,437 | September 1, 2017 | August 31, 2025 | DAS, ABHIK | reporter.nih.gov |
| Mechanisms controlling early human lung development | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $972,953 | August 1, 2018 | May 31, 2024 | AL-ALAM, DENISE | reporter.nih.gov |
| Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia - The "NONO trial" - a pragmatic, multi-center, de-implementation, stepped-wedge, cluster-randomized trial | NIH | National Heart, Lung, and Blood Institute | 2024 | $915,604 | September 17, 2024 | July 31, 2025 | JANCELEWICZ, TIMOTHY | reporter.nih.gov |
| Childrens' of Mississippi Neonatal Research Group | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $895,767 | April 1, 2023 | March 31, 2030 | BHATT, ABHAY J | reporter.nih.gov |
| Consortium Of MRI Biomarkers In Neonatal Encephalopathy (COMBINE) | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $878,936 | May 1, 2022 | April 30, 2027 | GRANT, PATRICIA ELLEN | reporter.nih.gov |
| Physiologic phenotyping of chronic lung disease of prematurity using MRI | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $867,431 | December 10, 2023 | November 30, 2027 | KOVANLIKAYA, ARZU | reporter.nih.gov |
| Leveraging multiomics and advanced mouse models to delineate mechanisms underlying sex‐specific differences in recovery and repair after neonatal hyperoxia exposure in the developing lung | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $817,521 | May 15, 2020 | April 30, 2025 | LINGAPPAN, KRITHIKA | reporter.nih.gov |
| Continued Pressure for Alveolar Protection: A Randomized Controlled Trial (CPAP Trial) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $805,722 | August 6, 2025 | July 31, 2030 | DAS, ABHIK | reporter.nih.gov |
| Mechanistic Roles of Adrenomedullin and its Signaling Receptors in Experimental Bronchopulmonary Dysplasia and Pulmonary Hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $792,500 | September 1, 2018 | December 31, 2023 | SHIVANNA, BINOY | reporter.nih.gov |
| Phase 1 trial of inhaled tobramycin in very preterm infants with bronchopulmonary dysplasia | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $792,000 | August 20, 2021 | July 31, 2025 | DOWNES, KEVIN JAMES | reporter.nih.gov |
| Early life hyperoxic exposure, lung innate immune responses, bronchopulmonary dysplasia and asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $780,000 | February 1, 2018 | January 31, 2024 | POPOVA, ANTONIA PETROVA | reporter.nih.gov |
| 1/2 Hydrocortisone for BPD Respiratory and Developmental Outcomes Study (HYBRiD Outcomes Study): Clinical Coordinating Center | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $776,967 | September 1, 2017 | August 31, 2025 | DEMAURO, SARA BONAMO | reporter.nih.gov |
| Regulatory T Cells And Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension | NIH | National Heart, Lung, and Blood Institute | 2025 | $773,868 | September 1, 2025 | June 30, 2030 | SHIVANNA, BINOY | reporter.nih.gov |
| Posttranscriptional modification in lung development and regeneration | NIH | National Heart, Lung, and Blood Institute | 2025 | $768,985 | September 1, 2025 | March 14, 2026 | QUE, JIANWEN | reporter.nih.gov |
| Pragmatic Research on Diuretic Management in Early BPD (PRIMED) Pilot | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $762,921 | January 1, 2023 | December 31, 2025 | KAPLAN, HEATHER CECILLE | reporter.nih.gov |
| Neonatal autonomic nervous system dysfunction as a predictor of autism spectrum disorder in preterm infants | NIH | National Institute of Mental Health | 2025 | $746,183 | April 15, 2025 | March 31, 2026 | DAIL, ROBIN BRITT | reporter.nih.gov |
| 1/2 Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia - The "NONO trial" - a pragmatic, multi-center, de-implementation, stepped-wedge, cluster-randomized trial | NIH | National Heart, Lung, and Blood Institute | 2024 | $743,657 | September 17, 2024 | July 31, 2031 | HARTING, MATTHEW TIHEN | reporter.nih.gov |
| Regulation of primary and secondary alveologenesis by FGF signaling pathways | NIH | National Heart, Lung, and Blood Institute | 2025 | $740,317 | January 29, 2025 | November 30, 2028 | ORNITZ, DAVID M | reporter.nih.gov |
| Adverse Effects of Neonatal CPAP on Lung Development | NIH | National Heart, Lung, and Blood Institute | 2025 | $740,196 | June 1, 2025 | March 31, 2029 | MACFARLANE, PETER | reporter.nih.gov |
| Improving Rural Neonatal Birth Outcomes through Neonatal Resuscitation Simulation Training | NIH | National Institute on Minority Health and Health Disparities | 2025 | $738,020 | August 1, 2025 | November 30, 2028 | OTTOLINI, MARY CATHERINE | reporter.nih.gov |
| High Efficiency Delivery of Surfactant Aerosols to Infants without Intubation | NIH | National Heart, Lung, and Blood Institute | 2021 | $734,852 | February 1, 2018 | January 31, 2024 | LONGEST, P. WORTH | reporter.nih.gov |
| Selective Targeting of Alveolar Capillaries in Neonatal Lung Injury | NIH | National Heart, Lung, and Blood Institute | 2025 | $730,070 | September 1, 2025 | May 31, 2029 | KALINICHENKO, VLADIMIR | reporter.nih.gov |
| MEOX2: A Critical Regulator of Alveolar Fibroblast Function | NIH | National Heart, Lung, and Blood Institute | 2025 | $721,826 | June 1, 2025 | March 31, 2029 | PERL, ANNE-KARINA THERESIA | reporter.nih.gov |
| Preclinical development of a synthetic lung surfactant dry powder aerosol for acute respiratory distress syndrome patients receiving different modes of ventilation support | NIH | National Heart, Lung, and Blood Institute | 2022 | $719,373 | September 22, 2022 | June 30, 2023 | LONGEST, P. WORTH | reporter.nih.gov |
| Non-invasive oscillometry to measure lung mechanics, response to treatments, and predict longer-term pulmonary outcomes among preterm infants: a prospective cohort study | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $695,244 | February 1, 2022 | January 31, 2027 | TRAVERS, COLM PETER | reporter.nih.gov |
| Salivary Diagnostics for Sepsis Screening in the Neonate | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $694,808 | August 9, 2019 | February 28, 2022 | MARON, JILL LAMANNA | reporter.nih.gov |
| The gut-lung axis influences the development of bronchopulmonary dysplasia | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $688,824 | July 1, 2020 | June 30, 2025 | WILLIS, KENT AVERY | reporter.nih.gov |
| The Impact of Late Preterm Steroids in Reducing Neonatal Respiratory Morbidity in the US | NIH | National Heart, Lung, and Blood Institute | 2025 | $667,776 | June 15, 2025 | April 30, 2030 | CLAPP, MARK ALLEN | reporter.nih.gov |
| Role of VEGF in Perinatal Hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 | $662,785 | June 20, 2001 | June 30, 2023 | ABMAN, STEVEN HERBERT | reporter.nih.gov |
| Metabolic mechanisms underlying bronchopulmonary dysplasia-associated pulmonary hypertension | NIH | National Heart, Lung, and Blood Institute | 2023 | $657,427 | July 1, 2023 | February 29, 2024 | YAO, HONGWEI | reporter.nih.gov |
| Genomic determinants of bronchopulmonary dysplasia development in humans and an animal model | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $652,320 | April 23, 2021 | March 31, 2025 | MOREIRA, ALVARO G | reporter.nih.gov |
| The Role of Lung Megakaryocytes in Airway Disease after Neonatal Hyperoxia | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $648,564 | April 1, 2022 | March 31, 2027 | DYLAG, ANDREW MICHAEL | reporter.nih.gov |
| Role of alveolar epithelial cell-derived cellular communication network factor 2 (CCN2) in alveologenesis and bronchopulmonary dysplasia | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $648,000 | August 1, 2020 | August 31, 2025 | ALAPATI, DEEPTHI | reporter.nih.gov |
| Role of Vitamin D in Lung Development and Bronchopulmonary Dysplasia | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $647,596 | February 15, 2020 | January 31, 2026 | MANDELL, ERICA WYNNE | reporter.nih.gov |
| Placental Proteins and Prematurity | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $641,883 | December 1, 2024 | November 30, 2029 | JANSSON, THOMAS | reporter.nih.gov |
| Transitional Alveolar Epithelial Cells in Normal Lung Development | NIH | National Heart, Lung, and Blood Institute | 2025 | $637,913 | September 10, 2025 | June 30, 2029 | MINOO, PARVIZ MINOO | reporter.nih.gov |
| Furosemide in severe bronchopulmonary dysplasia: comparative effectiveness of a duration and dosage informed treatment strategy | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $633,312 | September 4, 2020 | August 31, 2025 | BAMAT, NICOLAS AUGUSTO | reporter.nih.gov |
| NICHD Neonatal Research Network | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $620,630 | April 1, 1991 | March 31, 2025 | MARON, JILL LAMANNA | reporter.nih.gov |
| Origins of neonatal lung myofibroblasts | NIH | National Heart, Lung, and Blood Institute | 2025 | $594,583 | August 10, 2025 | May 31, 2029 | ZEPP, JAROD | reporter.nih.gov |
| VentFirst: A multicenter RCT of assisted ventilation during delayed cord clamping for extremely preterm infants | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $591,759 | May 25, 2016 | December 31, 2023 | FAIRCHILD, KAREN D | reporter.nih.gov |
| NICHD Neonatal Research Network (NRN) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $589,439 | April 1, 2011 | March 31, 2026 | SANCHEZ, PABLO J | reporter.nih.gov |
| Patient-Reported Outcomes to Understand Infant to Early Childhood Transition of Infants with Bronchopulmonary Dysplasia | NIH | National Heart, Lung, and Blood Institute | 2025 | $586,021 | February 1, 2025 | December 31, 2029 | LAGATTA, JOANNE M | reporter.nih.gov |
| Developmental Origins of COPD | NIH | National Heart, Lung, and Blood Institute | 2025 | $585,380 | April 1, 2025 | March 31, 2027 | BENJAMIN, JOHN | reporter.nih.gov |
| Multicenter Network of Neonatal Intensive Care Units-University of Texas at Houston (UT Houston) Clinical Center | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $581,646 | April 1, 2016 | March 31, 2023 | TYSON, JON E. | reporter.nih.gov |
| Role of novel SphK1 inhibitor, PF543 in therapy of Bronchopulmonary dysplasia and Airway remodeling | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $563,068 | August 15, 2018 | May 31, 2024 | HARIJITH, ANANTHA | reporter.nih.gov |
| Phase-1 Healthy adult human safety and pharmacokinetic study of AVR-48, a small molecule macrophage modulator to prevent bronchopulmonary dysplasia in at-risk pre-term infants | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $550,576 | May 1, 2023 | April 30, 2025 | ACHARYA, SUCHISMITA | reporter.nih.gov |
| Effect of Neonatal Hyperoxia on Alveolar Development and Infection | NIH | National Heart, Lung, and Blood Institute | 2021 | $536,581 | December 10, 2008 | August 31, 2023 | O'REILLY, MICHAEL A | reporter.nih.gov |
| Exosomal-mediated pyroptosis in ventilation-associated preterm brain injury | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $533,166 | July 15, 2020 | December 31, 2024 | SANTOS SCHMIDT, AUGUSTO F | reporter.nih.gov |
| The role of surfactant protein-A genetic variant and sex in pathogenesis of neonatal respiratory syncytial virus infection | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $521,643 | September 1, 2023 | August 31, 2028 | GANDHI, CHINTAN K | reporter.nih.gov |
| Efficacy of antenatal corticosteroids on the lung development of premature children in Bangladesh - the BiLDing-ACTION cohort | NIH | National Heart, Lung, and Blood Institute | 2025 | $517,972 | September 23, 2025 | June 30, 2029 | MCCOLLUM, ERIC DOUGLASS | reporter.nih.gov |
| The Role of Placental Maternal Vascular Underperfusion in Neonatal Pulmonary Hypertension | NIH | National Heart, Lung, and Blood Institute | 2022 | $517,030 | February 15, 2018 | January 31, 2024 | MESTAN, KAREN K | reporter.nih.gov |
| Impact of Early-in-life Disruption of Lung Development on Adult Lung Progenitor Function | NIH | National Heart, Lung, and Blood Institute | 2021 | $516,867 | September 1, 2018 | June 30, 2023 | SUN, XIN | reporter.nih.gov |
| An Integrated mHealth Strategy to Improve Newborn Resuscitation in Low and Lower-Middle Income Countries | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2024 | $513,859 | September 1, 2022 | August 31, 2025 | PATTERSON, JACQUELYN K | reporter.nih.gov |
| SCH: INT: Smart and Connected Health for Newborn Ventilation | NIH | National Institute of Biomedical Imaging and Bioengineering | 2022 to 2023 | $505,991 | September 30, 2019 | June 30, 2025 | DANDEKAR, KAPIL | reporter.nih.gov |
| Optimization and validation of single-nucleus RNA sequencing for non-human primate BPD lungs | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2023 | $504,176 | February 10, 2022 | January 31, 2025 | CATALTEPE, SULE | reporter.nih.gov |
| Neural Substrate of Outcomes after Neonatal Hypoxic Ischemic Encephalopathy | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $504,063 | March 1, 2022 | February 28, 2025 | OU, YANGMING | reporter.nih.gov |
| Mechanisms of Pulmonary Microbiota-Induced Inflammation and Vascular Dysfunction in Neonatal Lung Injury | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $502,848 | February 3, 2019 | January 31, 2024 | LAL, CHARITHARTH VIVEK | reporter.nih.gov |
| Predicting Pulmonary and Cardiac Morbidity in Preterm Infants with Deep Learning | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $498,960 | July 1, 2019 | July 31, 2024 | BEAM, ANDREW L. | reporter.nih.gov |
| Trajectories of Lung Function in Extremely Premature Infants | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $498,593 | September 1, 2019 | July 31, 2024 | JORDAN, BRIAN K | reporter.nih.gov |
| Postnatal Alveolar Formation | NIH | National Heart, Lung, and Blood Institute | 2021 | $498,360 | September 1, 2018 | July 31, 2024 | MINOO, PARVIZ MINOO | reporter.nih.gov |
| Mechanism of pulmonary endothelial cell heterogeneity and its role in disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $498,000 | September 1, 2023 | August 31, 2025 | VILA ELLIS, LISANDRA | reporter.nih.gov |
| Pulmonary vagal sensory neurons in chronic lung disease | NIH | National Heart, Lung, and Blood Institute | 2025 | $497,628 | August 15, 2025 | May 31, 2030 | MOURADIAN, GARY CHARLES | reporter.nih.gov |
| Role of hepatic IkBb-mediated sustained NFkB activation in neonatal lung injury and abnormal development | NIH | National Heart, Lung, and Blood Institute | 2021 | $490,696 | January 1, 2017 | November 30, 2022 | WRIGHT, CLYDE JASON | reporter.nih.gov |
| The Role of Placental Maternal Vascular Underperfusion in Neonatal Pulmonary Hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 | $484,884 | February 15, 2018 | September 30, 2021 | MESTAN, KAREN K | reporter.nih.gov |
| The role of IL-33 in hyperoxia-induced neonatal lung injury and bronchopulmonary dysplasia | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $480,168 | June 1, 2022 | May 31, 2026 | ELDREDGE, LAURIE CHRISTINE | reporter.nih.gov |
| Modeling the premature airway with neonatal airway basal cells | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $475,511 | June 11, 2021 | August 31, 2023 | LEROU, PAUL HUBERT | reporter.nih.gov |
| Genetic Basis of Normal and Pathological Alveologenesis in Lung Development | NIH | National Heart, Lung, and Blood Institute | 2021 | $464,366 | August 22, 2018 | June 30, 2023 | SUN, XIN | reporter.nih.gov |
| Rochester-Buffalo Neonatal Research Group | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $459,881 | April 1, 2011 | March 31, 2026 | BLISS, JOSEPH MARK | reporter.nih.gov |
| Ontogeny and Function of Early-Life Pulmonary Dendritic Cells | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $453,536 | February 10, 2023 | January 31, 2025 | HEADLEY, MARK BRYAN | reporter.nih.gov |
| Altered CD4+ T cell responses and resultant asthma following neonatal human metapneumovirus infection | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $453,110 | July 1, 2024 | June 30, 2029 | EDDENS, TAYLOR JOHN | reporter.nih.gov |
| Impact of prenatal exposures to copper from electronic nicotine delivery system (ENDS) aerosols on the immature neonatal pulmonary immune system and IL-10-mediated asthmatic responses | NIH | National Heart, Lung, and Blood Institute | 2025 | $450,000 | March 18, 2025 | January 31, 2030 | NOEL, ALEXANDRA | reporter.nih.gov |
| Inhaled ciclesonide - a phase I study in preterm infants | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $446,100 | August 5, 2024 | July 31, 2027 | SAMPATH, VENKATESH | reporter.nih.gov |
| Hox5 gene regulation of lung fibroblasts and distal lung extracellular matrix | NIH | National Heart, Lung, and Blood Institute | 2021 | $442,787 | September 1, 2018 | June 30, 2023 | WELLIK, DENEEN M | reporter.nih.gov |
| Biodegradable elastic patches for congenital diaphragmatic hernia treatment | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2023 | $441,125 | July 19, 2022 | June 30, 2025 | HONG, YI | reporter.nih.gov |
| The role of lung lipofibroblasts in alveolar differentiation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $427,625 | February 1, 2021 | January 31, 2025 | TALLQUIST, MICHELLE D | reporter.nih.gov |
| Novel non-invasive approach for predicting retinopathy of prematurity in premature neonates | NIH | National Eye Institute | 2023 to 2024 | $426,250 | September 30, 2023 | August 31, 2025 | DE PLAEN, ISABELLE G | reporter.nih.gov |
| Role of early life hyperoxia on mesenchymal stem cell fate: their impact on age related disease | NIH | National Institute on Aging | 2021 to 2022 | $423,500 | September 1, 2021 | May 31, 2024 | O'REILLY, MICHAEL A | reporter.nih.gov |
| Optimizing Betamethasone Therapy for Preventing Respiratory Distress Syndrome in Twin Pregnancy | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $419,375 | September 1, 2025 | June 30, 2027 | DE MORAES, NATALIA VALADARES | reporter.nih.gov |
| Lung selective CRISPR delivery for treatment of genetic surfactant disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $416,070 | April 15, 2022 | March 31, 2024 | ALAPATI, DEEPTHI | reporter.nih.gov |
| 1/2 The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial | NIH | National Heart, Lung, and Blood Institute | 2021 | $416,018 | September 17, 2021 | November 30, 2022 | FOGLIA, ELIZABETH | reporter.nih.gov |
| Respiratory Distress in Sheep with Hypophosphatasia: Etiology, Functional Consequences and Rescue | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $409,366 | August 19, 2024 | July 31, 2027 | GADDY, DANA | reporter.nih.gov |
| Wnt Signaling in Bronchopulmonary Dysplasia | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $400,227 | August 15, 2019 | July 31, 2024 | SUCRE, JENNIFER MALCOLMSRYGLEY | reporter.nih.gov |
| Placental Proteins and Prematurity | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $398,549 | September 24, 2021 | August 31, 2024 | JANSSON, THOMAS | reporter.nih.gov |
| Addressing Health Disparities in Chronic Lung Disease for Preterm Infants Through Parent Engagement | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $393,785 | August 15, 2024 | July 31, 2029 | SMITH, BRANDON | reporter.nih.gov |
| Genetic Epidemiology of Respiratory Function in Former Preterm Children | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $387,534 | January 15, 2018 | July 31, 2023 | HAYDEN, LYSTRA P. | reporter.nih.gov |
| Pilot trial comparing transpyloric to gastric feeding in very preterm infants with bronchopulmonary dysplasia | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 | $386,743 | September 5, 2024 | August 31, 2026 | JENSEN, ERIK ALLEN | reporter.nih.gov |
| Pressure in lung development and congenital diaphragmatic hernia | NIH | National Heart, Lung, and Blood Institute | 2021 | $383,414 | April 1, 2017 | March 31, 2024 | GLEGHORN, JASON PAUL | reporter.nih.gov |
| Leveraging multiomics and advanced mouse models to delineate mechanisms underlying sex‐specific differences in recovery and repair after neonatal hyperoxia exposure in the developing lung | NIH | National Heart, Lung, and Blood Institute | 2021 | $381,290 | May 15, 2020 | August 31, 2021 | LINGAPPAN, KRITHIKA | reporter.nih.gov |
| Effect of Indoor Fine Particulate Matter Exposure on Respiratory Health Outcomes in Premature Infants | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $380,500 | June 1, 2019 | May 31, 2025 | RICE, JESSICA LYNNE | reporter.nih.gov |
| AMP Kinase regulation in persistent pulmonary hypertension of the newborn | NIH | National Heart, Lung, and Blood Institute | 2021 | $380,000 | July 1, 2018 | December 31, 2023 | KONDURI, GIRIJA G. | reporter.nih.gov |
| Novel Small Molecule Drug Candidate for the Prevention of Bronchopulmonary Dysplasia | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 | $376,752 | May 3, 2023 | April 30, 2025 | KOLLISCH-SINGULE, MICHAELA CHRISTINA | reporter.nih.gov |
| Mobile Virtual Simulation Training in Essential Newborn Care for Healthcare Workers in Low and Middle Income Countries | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $371,988 | September 17, 2021 | August 31, 2023 | UMOREN, RACHEL A | reporter.nih.gov |
| Mentorship of Early-Career Clinicians in Bronchopulmonary Dysplasia Drug Therapies | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $367,512 | August 15, 2019 | July 31, 2024 | LAUGHON, MATTHEW | reporter.nih.gov |
| Improving the prediction of bronchopulmonary dysplasia by identifying kidney-based risk factors | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $364,392 | December 1, 2023 | November 30, 2028 | STARR, MICHELLE C | reporter.nih.gov |
| Hyperoxic Modulation of Thioredoxin Signaling | NIH | National Heart, Lung, and Blood Institute | 2021 | $356,565 | August 10, 2017 | June 30, 2023 | VITIELLO, PETER | reporter.nih.gov |
| Epigenomics of mononuclear phagocytes in prematurity associated lung disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $354,240 | January 15, 2018 | December 31, 2022 | SAJTI, ENIKO | reporter.nih.gov |
| Salivary miRNAs as Prognostic Markers of Pulmonary Hypertension Associated with Bronchopulmonary Dysplasia in Extremely Low Gestational Age Infants | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2024 | $347,238 | August 1, 2023 | July 31, 2028 | SIDDAIAH, ROOPA | reporter.nih.gov |
| 1/2 Milrinone for Prevention of Post-Patent Ductus Arteriosus Closure Syndrome in Extremely Preterm Infants (MIDAS Trial) – CCC | NIH | National Heart, Lung, and Blood Institute | 2024 | $342,731 | July 1, 2024 | June 30, 2025 | MCNAMARA, PATRICK J | reporter.nih.gov |
| IL17 mediates chorioamnionitis induced lung damage | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $342,190 | August 15, 2024 | July 31, 2029 | JAIN, VIRAL G | reporter.nih.gov |
| Microbiome of the Airway and the Risk for Bronchopulmonary Dysplasia in the Lungs of Extreme Preterms: The MARBLE Study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $326,619 | February 1, 2018 | January 31, 2024 | JENSEN, ERIK ALLEN | reporter.nih.gov |
| miR-17~92 Haploinsufficiency Influences Alveolar and Vascular Endothelial Development | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $326,160 | December 15, 2017 | May 31, 2023 | ROBBINS, MARY E | reporter.nih.gov |
| Home Oxygen Use for Infants with Bronchopulmonary Dysplasia: Balancing Infant, Family, and Health System Outcomes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $323,920 | January 1, 2018 | December 31, 2023 | LAGATTA, JOANNE M | reporter.nih.gov |
| Therapeutic Strategies for the Management of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $321,290 | December 5, 2024 | July 31, 2029 | GENTLE, SAMUEL J | reporter.nih.gov |
| Wnt-mediated epithelial-endothelial crosstalk in the generation and regeneration of the lung alveolus | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $318,816 | January 19, 2018 | April 30, 2023 | FRANK, DAVID BRIAN | reporter.nih.gov |
| In situ simulation of neonatal resuscitation to improve team performance and clinical outcomes | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $317,494 | December 5, 2016 | September 30, 2022 | LEE, HENRY CHONG | reporter.nih.gov |
| Adenosine Signaling in Bronchopulmonary Dysplasia | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $311,892 | January 1, 2018 | December 31, 2022 | DAVIES, JONATHAN | reporter.nih.gov |
| Biophysical force affects type 1 alveolar epithelial cell-mediated regulation of the pulmonary matrisome and lung development | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $310,392 | September 15, 2024 | August 31, 2029 | CALLAWAY, DANIELLE ARDEN | reporter.nih.gov |
| Optimizing Therapeutic delivery of MicroRNAs to prevent chronic lung disease in Preterm infants. | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $309,361 | December 10, 2016 | November 30, 2022 | ROGERS, LYNETTE KAY | reporter.nih.gov |
| Niclosamide Formulations for the Treatment of Influenza Infections | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $298,479 | July 8, 2022 | June 30, 2023 | FUJII, GARY | reporter.nih.gov |
| 1/2 Milrinone for Prevention of Post-Patent Ductus Arteriosus Closure Syndrome in Extremely Preterm Infants (MIDAS Trial) – CCC | NIH | National Heart, Lung, and Blood Institute | 2025 | $296,469 | July 1, 2024 | June 30, 2029 | MCNAMARA, PATRICK J | reporter.nih.gov |
| Clinical Decision Support System to Optimize Neonatal Nutrition and Growth | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 | $261,158 | August 1, 2022 | July 31, 2025 | KING, WILLIAM E | reporter.nih.gov |
| Enzyme-loaded nanoparticles for neonatal neuroprotection | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $253,237 | August 3, 2021 | May 31, 2023 | NANCE, ELIZABETH A | reporter.nih.gov |
| Cold milk as a novel therapy for dysphagia in preterm infants | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $231,000 | August 28, 2020 | July 31, 2023 | HANNA, NAZEEH N | reporter.nih.gov |
| Less Lumping, Smarter Splitting: Genomics and Metabolomics of Systemic Steroid Response in Bronchopulmonary Dysplasia | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $230,365 | September 1, 2020 | August 31, 2023 | NITKIN, CHRISTOPHER RYAN | reporter.nih.gov |
| Mechanism of pulmonary endothelial cell heterogeneity and its role in disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $209,088 | June 1, 2021 | August 31, 2023 | VILA ELLIS, LISANDRA | reporter.nih.gov |
| A Novel Glucocorticoid with Limited Adverse Effects in Neonatal Brain | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $195,625 | June 1, 2020 | May 31, 2022 | DEFRANCO, DONALD B | reporter.nih.gov |
| An Investigation of Omics for Bronchopulmonary Dypslasia | NIH | National Heart, Lung, and Blood Institute | 2025 | $192,672 | August 1, 2025 | July 31, 2030 | REISS, JONATHAN | reporter.nih.gov |
| Oral nitrate metabolism as a predictor for bronchopulmonary in preterm infants | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $185,625 | April 1, 2020 | March 31, 2023 | PATEL, RAKESH P. | reporter.nih.gov |
| The Role of Outpatient Diuretic Therapy in Bronchopulmonary Dysplasia | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2024 | $185,099 | April 1, 2023 | March 31, 2025 | COLLACO, JOSEPH MICHAEL | reporter.nih.gov |
| An Integrated mHealth Strategy to Improve Newborn Resuscitation in Low and Lower-Middle Income Countries | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $179,961 | September 9, 2020 | August 31, 2022 | PATTERSON, JACQUELYN K | reporter.nih.gov |
| Lung Injury Biomarkers to Endotype Respiratory Trajectories in Established Bronchopulmonary Dysplasia: The LIBERATE-BPD Study | NIH | National Heart, Lung, and Blood Institute | 2025 | $179,330 | August 1, 2025 | July 31, 2030 | KIELT, MATTHEW | reporter.nih.gov |
| Role of KLF6 in Lung Development | NIH | National Heart, Lung, and Blood Institute | 2025 | $173,259 | September 1, 2025 | August 31, 2028 | DUONG, THU ANH | reporter.nih.gov |
| Impact of ATP-binding cassette A3 (ABCA3) mutations on alveolar type 2 cell function and genetic complementation | NIH | National Center for Advancing Translational Sciences | 2024 | $173,175 | August 1, 2024 | July 31, 2025 | MCCRAY, PAUL B | reporter.nih.gov |
| Understanding the impact of targeting the epigenetic regulation of lung stem cells in congenital lung disease | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 | $167,000 | September 1, 2023 | August 31, 2025 | ROWBOTHAM, SAMUEL PHILIP | reporter.nih.gov |
| Developing models of placenta-driven developmental lung injury in human preeclampsia | NIH | National Heart, Lung, and Blood Institute | 2025 | $166,752 | September 1, 2025 | August 31, 2030 | TAGLAUER, ELIZABETH | reporter.nih.gov |
| The Effect of Hyperoxia on Neonatal Respiratory Progenitor Cell Function | NIH | National Heart, Lung, and Blood Institute | 2025 | $166,395 | September 1, 2025 | August 31, 2030 | RAI, NOORALAM | reporter.nih.gov |
| A universal ambient air-oxygen blender to treat respiratory distress in newborns | NIH | National Heart, Lung, and Blood Institute | 2022 | $165,600 | September 1, 2022 | August 31, 2023 | CARVALHO, BRUCE LAWRENCE | reporter.nih.gov |
| ZFHX4 sets alveolar fibroblast differentiation potential of mesenchymal progenitors in the fetal lung | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 | $164,990 | August 1, 2024 | July 31, 2026 | AI, XINGBIN | reporter.nih.gov |
| OPTImal vasoPRESsor in persistent pulmonary hypertension of the newborn (OPTIPRES) | NIH | National Heart, Lung, and Blood Institute | 2025 | $164,916 | August 1, 2025 | July 31, 2030 | SANKARAN, DEEPIKA | reporter.nih.gov |
| S-nitrosoglutathione reductase and airways hyperreactivity in murine bronchopulmonary dysplasia | NIH | National Heart, Lung, and Blood Institute | 2021 | $163,603 | July 14, 2017 | April 30, 2023 | RAFFAY, THOMAS MICHAEL | reporter.nih.gov |
| Mechanisms of Hydrocortisone Regulation of the Perinatal Pulmonary Vasculature | NIH | National Heart, Lung, and Blood Institute | 2021 | $163,080 | January 9, 2017 | June 30, 2022 | PEREZ, MARTA | reporter.nih.gov |
| The role of IL-33 in hyperoxia-induced neonatal lung injury and bronchopulmonary dysplasia | NIH | National Heart, Lung, and Blood Institute | 2021 | $161,216 | December 15, 2019 | May 31, 2022 | ELDREDGE, LAURIE CHRISTINE | reporter.nih.gov |
| Regulatory T cells and Inflammatory Injury of the Developing Murine Lungs | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $160,000 | March 8, 2021 | May 31, 2023 | SHIVANNA, BINOY | reporter.nih.gov |
| Neonatal Hypovolemic Cardiac Arrest: Role of Early Rapid Volume Resuscitation | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 | $160,000 | August 1, 2023 | July 31, 2025 | SANKARAN, DEEPIKA | reporter.nih.gov |
| Optimal Inspired Oxygen during Chest Compressions in Neonatal Resuscitation | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $159,500 | January 1, 2021 | December 31, 2023 | RAWAT, MUNMUN | reporter.nih.gov |
| Salivary miRNAs as Prognostic Markers of Pulmonary Hypertension Associated with Bronchopulmonary Dysplasia in Extremely Low Gestational Age Infants | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $159,422 | August 1, 2023 | July 31, 2028 | SIDDAIAH, ROOPA | reporter.nih.gov |
| Exploring the role of Hedgehog pathway-Primary cilia axis in human lung alveologenesis and disease | NIH | National Heart, Lung, and Blood Institute | 2025 | $156,168 | August 1, 2025 | July 31, 2027 | BELGACEMI, RANDA SONIA | reporter.nih.gov |
| Effects of Earlier And Higher Vitamin D Supplementation in Extremely Preterm Newborns at 2 Years Of Age | NIH | National Center for Advancing Translational Sciences | 2025 | $156,000 | September 1, 2025 | August 31, 2027 | ROMERO LOPEZ, MARIA DEL MAR | reporter.nih.gov |
| High-Content Analysis to Accelerate Mechanistic and Therapeutic Identification for ABCA3 Deficiency | NIH | National Center for Advancing Translational Sciences | 2025 | $155,500 | June 1, 2025 | May 31, 2027 | WAMBACH, JENNIFER | reporter.nih.gov |
| Regulation of Elastin Assembly during Saccular Stage Lung Development | NIH | National Heart, Lung, and Blood Institute | 2021 | $147,797 | July 5, 2017 | June 30, 2022 | BENJAMIN, JOHN | reporter.nih.gov |
| Racial Disparities in Accuracy of Pulse Oximetry | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2023 | $145,072 | March 1, 2022 | February 28, 2025 | SIEFKES, HEATHER M | reporter.nih.gov |
| Pilot Study of an Inhaled Treatment for Bronchopulmonary Dysplasia | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $140,312 | August 1, 2021 | July 31, 2025 | RAFFAY, THOMAS MICHAEL | reporter.nih.gov |
| Three-dimensional Confocal Microscopy Visualization and AFM-IR Chemical Mapping of Lung Surfactant Monolayer Collapse Morphologies | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $134,953 | September 15, 2023 | September 14, 2026 | MCALLISTER, ZACHARY D | reporter.nih.gov |
| Cord Blood Adductomics in Bronchopulmonary Dysplasia | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $131,961 | December 10, 2019 | September 30, 2021 | MESTAN, KAREN K | reporter.nih.gov |
| Determining the Role of Myrf in the Lung Mesothelium | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $119,269 | August 1, 2021 | July 31, 2024 | LUNA, GIDSELA | reporter.nih.gov |
| "Preterm lung and brain responses to mechanical ventilation and corticosteroids" | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $113,625 | July 6, 2020 | December 31, 2023 | HILLMAN, NOAH H | reporter.nih.gov |
| The Role of Developmental Dysanapsis in Lung Development Throughout the Lifespan in Experimental Bronchopulmonary Dysplasia | NIH | National Heart, Lung, and Blood Institute | 2025 | $106,391 | September 9, 2025 | August 31, 2027 | MCGINN, ELIZABETH | reporter.nih.gov |
| PPARg as a key regulator of sex-based differences in bronchopulmonary dysplasia | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $97,788 | June 1, 2020 | May 31, 2023 | HAYWARD-PIATKOVSKYI, BRIELLE | reporter.nih.gov |
| Preterm Infant Outcomes Following Changes in Oxygen Saturation Targets in California Neonatal ICUs | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $92,612 | April 1, 2020 | September 30, 2022 | HAGADORN, JAMES I. | reporter.nih.gov |
| Laminin Binding Integrins in Lung Development | NIH | National Heart, Lung, and Blood Institute | 2021 | $86,000 | August 5, 2020 | July 31, 2022 | PLOSA, ERIN J | reporter.nih.gov |
| Tracheal occlusion and nuclear YAP activation in the congenital diaphragmatic hernia fetal lung | NIH | National Heart, Lung, and Blood Institute | 2025 | $84,724 | September 2, 2025 | September 1, 2027 | STEWART, LATOYA | reporter.nih.gov |
| Metagenomics of the circulating blood microbiome and systemic inflammation in preterm infants | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $80,000 | March 4, 2020 | February 28, 2023 | PAMMI, MOHAN | reporter.nih.gov |
| Amniotic fluid entrains embryo-wide branching morphogenesis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $78,052 | August 1, 2025 | July 31, 2028 | WAAS, BRIDGET | reporter.nih.gov |
| The role of lung capillary endothelial cells in NFkB-directed alveolarization | NIH | National Heart, Lung, and Blood Institute | 2025 | $75,520 | September 1, 2025 | August 31, 2028 | SVEIVEN, STEFANIE NOEL | reporter.nih.gov |
| The role of transcription factor MEOX2 in lipofibroblast function during alveolarization | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $73,258 | February 2, 2022 | November 17, 2023 | RICCETTI, MATTHEW | reporter.nih.gov |
| The role of sex chromosomes in neonatal hyperoxic lung injury | NIH | National Heart, Lung, and Blood Institute | 2025 | $49,538 | August 1, 2025 | May 31, 2028 | ALBERT, ROSE MEI LIU | reporter.nih.gov |
| Mechanical Control of Smooth Muscle Differentiation During Mouse Lung Branching | NIH | National Heart, Lung, and Blood Institute | 2022 | $46,262 | August 1, 2017 | May 15, 2023 | JASLOVE, JACOB MICHAEL | reporter.nih.gov |
| Akt-mediated phosphorylation of hsp70 regulates mitochondrial localization of SOD2 and oxidative stress in pulmonary artery endothelial cells during postnatal transition | NIH | National Heart, Lung, and Blood Institute | 2021 | $41,256 | September 1, 2016 | January 9, 2022 | AFOLAYAN, ADELEYE J | reporter.nih.gov |
| Effect of Indoor Fine Particulate Matter Exposure on Respiratory Health Outcomes in Premature Infants | NIH | National Institute of Environmental Health Sciences | 2021 | $36,715 | June 1, 2019 | September 19, 2021 | RICE, JESSICA LYNNE | reporter.nih.gov |
| Mechanical Control of Smooth Muscle Differentiation During Mouse Lung Branching | NIH | National Heart, Lung, and Blood Institute | 2021 | $35,282 | August 1, 2017 | December 31, 2021 | JASLOVE, JACOB MICHAEL | reporter.nih.gov |
| Dissecting the Role of Mechanical Forces in the Branching Morphogenesis of the Mouse Bronchial Tree | NIH | National Heart, Lung, and Blood Institute | 2025 | $33,538 | September 3, 2025 | September 2, 2027 | HUANG, NILES | reporter.nih.gov |
| MESOTHELIAL MECHANOTRANSDUCTION AS A KEY REGULATOR OF EMBRYONIC LUNG GROWTH | NIH | National Heart, Lung, and Blood Institute | 2021 | $14,207 | September 1, 2018 | January 31, 2022 | GILBERT, RACHEL | reporter.nih.gov |
| Therapeutic Strategies for the Management of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 | $10,000 | August 6, 2024 | September 17, 2024 | GENTLE, SAMUEL J | reporter.nih.gov |
Organizations
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 129 | $72,041,039 | 0 | $0 |
| 2024 | 123 | $64,997,523 | 0 | $0 |
| 2023 | 129 | $84,983,453 | 0 | $0 |
| 2022 | 121 | $63,027,995 | 0 | $0 |
| 2021 | 134 | $66,267,555 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.